News

Prairie Women's Health Centre of Excellence is pleased to announce the publication of "Young and Aboriginal: Labour and Birth Experiences of Teen Mothers in Winnipeg".

Click here to read the full report.

The exploratory project involved talking with nineteen young Aboriginal mothers in Winnipeg with the following goals:

•  To draw attention to the labour and birth experiences of young Aboriginal mothers in Winnipeg;

•  To discuss young Aboriginal mothers’ perceptions of treatment, services and supports received from medical professionals in hospital settings during labour and birth; and

•  To outline young Aboriginal mothers’ labour and birthing needs and their suggestions for positive birthing experiences and outcomes.

Findings in the report echo that of other Aboriginal teen advocates who are calling for more research specifically focused on this population group and the need for an increased awareness regarding their maternal health needs.

For more information, or if you would like a hard copy of the report please contact:

Roberta Stout

Researcher - Aboriginal Women's Health

Prairie Women's Health Centre of Excellence

56 The Promenade

Winnipeg, MB R3B 3H9

Ph: (204) 982-6632

Fax: (204) 982-6637

www.pwhce.ca

 

 

Tags teen labor  aboriginal  document 

Posted by Michelle Allard at 1:54 PM 0 Comments

Click here to view a five minute youtube video sponsored in part by the GP Access in australia which gives an interesting look at understanding chronic pain for the patient. This video was shared at an FMF session on chronic pain behaviors and perspectives (patient & clinician).

Tags chronic pain 

Posted by Michelle Allard at 1:29 PM 0 Comments

CNA is still looking for external abstract reviewers. Each abstract reviewer will be given a complimentary convention registration for the Biennium that will be held in Vancouver next year.

Contact Elizabeth by Friday, December 9.

Elizabeth Morin
Administrative Assistant/Adjointe administrative, Professional Practice & Regulation division / Division de la pratique professionnelle et de la réglementation
The Canadian Nurses Association/L'Association des infirmières et des infirmiers du Canada
50 Driveway

Ottawa ON K2P 1E2
Tel: 613-237-2159, ext 234
Fax: 613-237-3520
E-mail: emorin@cna-aiic.ca

Tags cna  abstract 

Posted by Michelle Allard at 3:09 PM 0 Comments

Information Update
December 5, 2011
For immediate release

OTTAWA - Health Canada has completed a safety review of drospirenone-containing oral contraceptives (marketed under the brand names Yasmin and Yaz) with respect to the risk of blood clots (venous thromboembolism, or VTE). The review determined that drospirenone-containing birth control pills may be associated with a risk of blood clots that is 1.5 to 3 times higher than other birth control pills.

Blood clots are a rare but well known side effect associated with all birth control pills. The risks of blood clots are higher with pregnancy and childbirth than with oral contraceptives.

As part of its review, Health Canada considered several recent observational studies evaluating the risk of blood clots with drospirenone-containing oral contraceptives versus other oral contraceptives. Overall, the body of current evidence suggests that the risk of blood clots is 1.5 to 3 times higher with oral contraceptives that contain drospirenone relative to those that contain levonorgestrel, a different hormone.

Overall the risk of blood clots with any oral contraceptive (including Yasmin and Yaz) is very small.

To put this into perspective, if the estimated risk of developing a blood clot among women taking a levonorgestrel-containing birth control pill is 1 in 10,000 women per year, as some studies have estimated, then the risk in women taking a drospirenone birth control pill is about 1.5 to 3 women in 10,000 per year.

The drug labels for Yasmin and Yaz have been updated to include information on the studies and the recommendation that, when prescribing an oral contraceptive, health professionals consider the risks and benefits of drospirenone-containing oral contraceptives for a specific patient in light of her risk for developing blood clots, and relative to the risks and benefits of other birth control pills on the market.

Women with questions or concerns about their birth control pill should talk to their healthcare professional. When choosing an oral contraceptive, women should talk to their health professional about their risk for blood clots. Known factors that increase the risk of blood clots include smoking, being overweight (obesity), and a family history of blood clots.

Canadians are reminded that birth control pills of any type should not be used by women who have had a blood clot or who have certain risk factors. This includes women over the age of 35 who smoke heavily (more than 15 cigarettes/day), as they are at an increased risk.

Patients who think they are experiencing symptoms of a blood clot should seek immediate medical attention and mention any medications they may be taking, including birth control pills. Symptoms of a blood clot may include persistent leg swelling, leg pain or tenderness, chest pain, or sudden shortness of breath or difficulty breathing.

Drug labels, or "Product Monographs," contain important prescribing and safety information for health professionals and patients, and are available by search of Health Canada's Drug Product Database.

How to report side effects to health products

To report suspected adverse reaction to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send to us using one of these methods:

Fax: 1-866-678-6789

Internet: MedEffect™ Canada

Mail (Get a postage-paid label):
Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, ON, Address Locator 0701E
K1A 0K9

Tags oral contraceptive  health canada 

Posted by Michelle Allard at 3:07 PM 0 Comments